your market intelligence analyst
Search Results
27 results
Your search is now limited to «Diabetes Clinical Trials» expert search.
Business Wire 09/16/2019 15:48
LA ROCHELLE, Francia--(BUSINESS WIRE)--VALBIOTIS (Paris:ALVAL) (FR0013254851 – ammissibile per ALVAL / PEA/SME), una società di Ricerca e Sviluppo impegnata nell’innovazione scientifica per prevenire e combattere le malattie del metabolismo, oggi ha annunciato la presentazione di uno studio preclinico condotto dal laboratorio CarMeN sul principio attivo TOTUM-63, nell’ambito della 55a edizione del Congresso annuale della European Association for the Study of Diabetes che si svolgerà a Barcellon.
Business Wire 09/16/2019 11:40
LA ROCHELLE, France--(BUSINESS WIRE)--Regulatory News : VALBIOTIS (Paris:ALVAL) (FR0013254851 – ALVAL / éligible PEA/PME), entreprise de Recherche & Développement engagée dans l’innovation scientifique, pour la prévention et la lutte contre les maladies métaboliques, annonce la présentation d’une étude préclinique réalisée par le laboratoire CarMeN sur la substance active TOTUM-63 au 55e congrès de l’European Association for the Study of Diabetes, du 16 au 20 septembre 2019 à Barcelone (Esp.
Business Wire 09/16/2019 11:40
The results of the Phase IIA international randomized, placebo-controlled study showed that in patients with prediabetes, TOTUM-63 reduces fasting blood glucose and blood glucose at 2 hours, two risk factors of type 2 diabetes.
FeedNavigator (EU) 09/15/2019 02:08
Type 2 diabetes mellitus (DM) is associated with an increased risk of cardiovascular disease (CVD). Atrial fibrillation (AF) and stroke are both forms of CVD that have major consequences in terms of disabilities and death among patients with diabetes; however, they are less present in the preoccupations of scientific researchers as a primary endpoint of clinical trials. Several publications have found DM to be associated with a higher risk for both AF and stroke; some of the main drugs used for glycemic control have been found to carry either increased, or decreased risks for AF or for stroke in DM patients. Given the risk for thromboembolic cerebrovascular events seen in AF patients, the question arises as to whether stroke and AF occurrin.
FeedNavigator (EU) 09/13/2019 10:37
The randomized controlled trial compares the telephone and Facebook-delivered Communication & Coping intervention, which promotes the use of adaptive coping strategies and positive parenting practices, to a diabetes education control condition on diabetes outcomes and psychosocial outcomes in adolescents with T1D ...

Automotive Industries

Business Issues

Companies - Public

Companies - Venture Funded

Global Markets

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Market Research Topics

Political Entities


Strategic Scenarios